Patented Non Invasive Blood Glucose Device

We have always been dedicated to
pushing the boundaries of innovation in healthcare.
We are thrilled to introduce you to our latest innovation Non-invasive
blood glucose meter. This revolutionary product is poised to address
critical challenges within the healthcare sector, including [NO blood,
NO Pain, NO needle, No prick, No spread of infection, No
bio-contamination.]. Our team of expert researchers, engineers, and
healthcare professionals has worked tirelessly to develop product
which is designed to make the life of a diabetic patient more
comfortable with no pain and multiple tests at no cost.
The potential impact on patient care, healthcare
providers, and the entire industry is immense. We believe that it has
the power to:
Enhance patient outcomes with no restrictions or number of tests you can
perform in a day for blood sugar, you can keep your blood sugar at
controlled levels, it is boon to the diabetic patients. This device
stores the blood sugar readings and can be downloaded and sent to your
healthcare professional for advice thus Streamlining healthcare
operation and reducing cost and time.
This device empowers healthcare professionals. It is light and small
to carry in your pocket and helps health care professionals to make
immediate assessment of their patient blood sugar levels.
We are seeking strategic partners and investors who share our vision
for the future of healthcare. Your support and investment will play a
pivotal role in accelerating the development, testing, and
commercialization. With your backing, we can bring this
groundbreaking solution to market faster and impact more lives positively.
Terms and conditions for dilution of shares
1.We offer to issue 15% of shares to any investor who is in a position to invest 10cr or equivalent 1.2 million US $

2. Our alternate offer . The investor can take the 100% equity in the company for a consideration of a one time payment of 20cr or 2.5 million US $and obtain the license of patent for India for the life of the patent 20 years. The global patent PCT filed will be with the Patent holders , it can be Licensed for other countries other than India globally for a Royalty Fee. The Inventors will continue to play an active role and support the company R&D and product development till the product is launched in the market.

3. The investor can Merge to the existing entity of the investor by paying 10cr INR to the Founders or 1.2 Million US $ .Further issue shares worth 10 cr INR or 1.25 Million US$ In the investors company or the new merged entity. Where in company will issue to the company license to produce and sell the product in India for the life time of the Indian patent 20 yea If you are interested in learning more about and how your
investment can make a meaningful impact, we would be delighted to
arrange a meeting at your convenience.